Page last updated: 2024-10-16

carbamates and Inflammatory Bowel Diseases

carbamates has been researched along with Inflammatory Bowel Diseases in 1 studies

Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.

Research Excerpts

ExcerptRelevanceReference
"Givinostat treatment mediated an accelerated wound closure in scratch assays."1.51HDAC inhibitors promote intestinal epithelial regeneration via autocrine TGFβ1 signalling in inflammation. ( Friedrich, M; Gerbeth, L; Gerling, M; Glauben, R; Keye, J; Rosenthal, R; Schmidt, F; Siegmund, B; Steiger, K; Weichert, W; Weidinger, C; Wu, H, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Friedrich, M1
Gerbeth, L1
Gerling, M1
Rosenthal, R1
Steiger, K1
Weidinger, C1
Keye, J1
Wu, H1
Schmidt, F1
Weichert, W1
Siegmund, B1
Glauben, R1

Other Studies

1 other study available for carbamates and Inflammatory Bowel Diseases

ArticleYear
HDAC inhibitors promote intestinal epithelial regeneration via autocrine TGFβ1 signalling in inflammation.
    Mucosal immunology, 2019, Volume: 12, Issue:3

    Topics: Animals; Autocrine Communication; Carbamates; Cells, Cultured; Colitis; Disease Models, Animal; Elec

2019